Welcome to our dedicated page for RYMDF news (Ticker: RYMDF), a resource for investors and traders seeking the latest updates and insights on RYMDF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RYMDF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RYMDF's position in the market.
Relay Medical Corp. (RYMDF) and Fio Corporation have secured a sales agreement with the U.S. Government through USAID to deploy the Fionet Platform in the Democratic Republic of the Congo (DRC) to combat malaria. This agreement identifies 144 health sites to utilize Fionet's connected devices and AI software. USAID, a leading aid agency, allocates a significant portion of its budget for malaria intervention. The Fionet system has demonstrated superior accuracy in malaria case tracking compared to conventional methods, showcasing its potential for broader deployment across central Africa.
Relay Medical Corp. has secured a contract with StarFish Medical to provide the Cybeats integrated cybersecurity platform, aimed at enhancing security for connected medical devices. This agreement includes an annual subscription for Cybeats’ Software as a Service (SaaS) solution and the utilization of the SBOM software for monitoring security. This partnership responds to growing concerns regarding cybersecurity in healthcare, particularly after recent attacks. The Global IoMT market is projected to reach USD $284.5 billion by 2027, indicating a significant growth opportunity for Cybeats.
Relay Medical Corp. (OTC: RYMDF) will host its first Cybersecurity panel discussion on June 22, 2021, featuring notable industry speakers including Chuck Brooks and Chris Blask. The discussion will cover essential topics related to the Executive Order on cybersecurity by President Joe Biden and the challenges faced by the Internet of Things (IoT) sector. Following the event, a video recording will be available on the company's YouTube channel. This initiative highlights Relay's commitment to improving cybersecurity in connected devices.
Relay Medical Corp. has appointed Chris Blask to its Advisory Board, enhancing its cybersecurity capabilities. With nearly 30 years in the field, Blask invented the Digital Bill of Materials and has held significant roles in cybersecurity innovation. His expertise will aid Relay in operationalizing Software Bill of Materials (SBOM), crucial for effective supply chain security. CEO Yoav Raiter highlighted Blask’s deep understanding of enterprise-level protection, particularly regarding IoT products. Relay Medical, based in Toronto, focuses on advancing diagnostics and AI data science technologies.
Relay Medical Corp. (RYMDF) praises a recent executive order by President Biden prioritizing cybersecurity, mandating the use of a Software Bill of Materials (SBOM) to enhance software supply chain integrity. This aligns with Relay's Cybeats cybersecurity platform, already designed for SBOM implementation. With growing concerns over cyber attacks, the federal government seeks to partner with the private sector to adapt to evolving threats. Relay is scaling its SBOM solution and appointed Chuck Brooks as a Special Advisor, highlighting its potential in the projected $154.59 billion Critical Infrastructure Protection market.
Relay Medical and Fio Corporation, through their joint venture Fionet Rapid Response Group (FRR), report successful on-site biosecurity testing at Toronto Pearson Airport. In its first month, the Fionet Platform conducted antigen tests on 8,000 individuals with an average turnaround time of 30 minutes. The GTAA selected Fionet for testing, reporting, and passenger logistics, deploying all essential modules. The introduction of PCR testing is also underway, enhancing health safety protocols. This initiative underscores the commitment to biosecurity and operational efficiency at one of Canada's busiest airports.
Relay Medical Corp. (OTC: RYMDF) announced a significant partnership with LifeLabs to deploy the Fionet Platform for rapid COVID-19 testing across Canada. This technology offers automated, quality-controlled testing with results in 15 minutes, making it accessible in community settings, including airports. LifeLabs, supporting over 20 million patient visits and conducting 100 million tests annually, enhances Relay Medical's reach and market presence. Each Fionet device can process 60 tests per hour, opening up substantial business opportunities in rapid testing services.
Relay Medical Corp. welcomes Chuck Brooks, a renowned global cybersecurity expert, to its Advisory Board. With his extensive background and accolades, including being named a top cybersecurity influencer, Brooks will enhance Cybeats, the company’s IoT security platform. Cybeats addresses the $73 billion IoT security market, offering solutions crucial for protecting critical infrastructure. Brooks’ insights aim to strengthen the platform's capabilities, ensuring robust defense against cyber threats as the number of connected devices continues to rise.
Relay Medical Corp. is well-capitalized with over CAD $9 million in treasury and anticipates first commercial revenues in Q2 2021 through its Fionet platform and Cybeats cybersecurity product. The company has established partnerships, including with LifeLabs for COVID-19 testing in community settings and USAID for deployments in the Democratic Republic of the Congo. Relay's Fionet platform optimizes pandemic screening solutions, and the acquisition of Cybeats positions the company to tap into the $73 billion IoT security market. Relay expects to scale operations and support significant testing engagements.
Relay Medical Corp. (RYMDF) and Fio Corporation have announced a partnership with LifeLabs to implement the Fionet Platform for COVID-19 rapid testing across Canada. LifeLabs, the largest laboratory testing service in the country, will use the Fionet Platform for efficient, real-time testing and reporting in community settings, including airports and small businesses. This initiative aims to provide hundreds of thousands of tests monthly, thus enhancing access to quality testing as the country navigates the pandemic recovery.
